201 related articles for article (PubMed ID: 20937024)
1. Use of transgenic mice as models for prostate cancer chemoprevention.
Nguewa PA; Calvo A
Curr Mol Med; 2010 Nov; 10(8):705-18. PubMed ID: 20937024
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
[TBL] [Abstract][Full Text] [Related]
3. Advances in prostate cancer chemoprevention: a translational perspective.
Nambiar D; Singh RP
Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
[TBL] [Abstract][Full Text] [Related]
4. SELECT: the selenium and vitamin E cancer prevention trial.
Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
Urol Oncol; 2003; 21(1):59-65. PubMed ID: 12684129
[TBL] [Abstract][Full Text] [Related]
5. Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.
Wang L; Zhang J; Zhang Y; Nkhata K; Quealy E; Liao JD; Cleary MP; Lü J
Prostate; 2011 Sep; 71(13):1429-40. PubMed ID: 21360561
[TBL] [Abstract][Full Text] [Related]
6. The future of prostate cancer prevention.
Brawley OW; Barnes S; Parnes H
Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
[TBL] [Abstract][Full Text] [Related]
7. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease.
Adhami VM; Siddiqui IA; Sarfaraz S; Khwaja SI; Hafeez BB; Ahmad N; Mukhtar H
Clin Cancer Res; 2009 Mar; 15(6):1947-53. PubMed ID: 19276266
[TBL] [Abstract][Full Text] [Related]
8. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
[TBL] [Abstract][Full Text] [Related]
9. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.
Ledesma MC; Jung-Hynes B; Schmit TL; Kumar R; Mukhtar H; Ahmad N
Mol Med; 2011; 17(1-2):134-43. PubMed ID: 20882260
[TBL] [Abstract][Full Text] [Related]
10. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
[TBL] [Abstract][Full Text] [Related]
11. Prevention of prostate cancer.
DePrimo SE; Shinghal R; Vidanes G; Brooks JD
Hematol Oncol Clin North Am; 2001 Jun; 15(3):445-57. PubMed ID: 11525290
[TBL] [Abstract][Full Text] [Related]
12. Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.
McCormick DL; Rao KV; Johnson WD; Bosland MC; Lubet RA; Steele VE
Cancer Prev Res (Phila); 2010 Mar; 3(3):381-92. PubMed ID: 20145190
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer chemoprevention.
Sandhu GS; Nepple KG; Tanagho YS; Andriole GL
Semin Oncol; 2013 Jun; 40(3):276-85. PubMed ID: 23806493
[TBL] [Abstract][Full Text] [Related]
14. A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model.
Zhang Y; Zhang J; Wang L; Quealy E; Gary BD; Reynolds RC; Piazza GA; Lü J
Cancer Prev Res (Phila); 2010 Jul; 3(7):885-95. PubMed ID: 20587701
[TBL] [Abstract][Full Text] [Related]
15. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of prostate cancer.
Kucuk O
Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
[TBL] [Abstract][Full Text] [Related]
17. Is There a Future for Chemoprevention of Prostate Cancer?
Bosland MC
Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
[TBL] [Abstract][Full Text] [Related]
19. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
[TBL] [Abstract][Full Text] [Related]
20. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
